Biolog | GenomeWeb


Researchers from the Greenwood Genetic Center have reported positive results that confirm their earlier findings in an effort to develop a test for autism spectrum disorders using Biolog's phenotype array technology.

The National Institutes of Health has awarded Greenwood Genetic Center $275,000 to support the development of a test for autism spectrum disorders. GGC will use Biolog's Phenotype Microarray platform in the planned two-year study.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Biolog today announced new distributors for its products in Europe.

CEO Barry Bochner said that Biolog will use the funds to continue adapting its Phenotype Microarray platform to study Mycobacterium tuberculosis and other fastidious pathogens, expand its Microbial Identification System to cover more fastidious species, and work with researchers at Texas A&M University to study gene function in Mycobacterium.

Appearing in the online editions of Fungal Genetics and Biology and Microbiology, the papers describe the use of Biolog's Phenotype Microarray platform to research secondary pathways in F. graminearum, which is responsible for head blight and crop losses.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.